All News

A retrospective analysis of real-world data found a discrepancy between actual care and the recommendations from clinical trials for patients with mantle cell lymphoma, resulting in outcomes that were worse than in trials.

Patients with a cough lasting more than 8 weeks are diagnosed with chronic cough, and for a subpopulation of those patients there is no treatable underlying cause of their cough, said Peter Dicpinigaitis, MD, professor of medicine at the Albert Einstein College of Medicine and director of the Montefiore Cough Center.

Abstracts cover the cost of cancer-related diarrhea, 30-day readmission rates, and how perceptions of the likelihood of survival affect end-of-life care.

An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.

Ivo Abraham, PhD, RN, a professor with the University of Arizona Health Sciences in the Department of Pharmacy Practice, discusses how the COVID-19 pandemic is likely to impact oncology biosimilar utilization.

Two abstracts presented recently at the American Society of Clinical Oncology annual meeting offered promising data for 2 CAR T-cell therapies, one in relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL) and one in R/R multiple myeloma.

A pharmacist-led collaborative medication management service reduced problems associated with polypharmacy in older adults with chronic kidney disease (CKD).

The proposed changes to the payment model for end stage renal disease (ESRD) would make it the first payment model under the CMS Innovation Center to directly address health equity by incentivizing increased rates of home dialysis and kidney transplants.

Years of research has shown that in cancers like melanoma, liquid biopsy enables the detection of biomarkers, such as circulating tumor cells, circulating tumor DNA, and exomes.

Not all asthma is created equal, nor will all therapies work for all patients. With continued innovations in asthma treatments offering new, improved options for patients, we are more prepared than ever to address uncontrolled asthma head-on.

The measure is designed to end surprise medical billing and balance billing, taking the first step to implement the so-called No Surprises Act that passed Congress at the end of last year.

New data suggest a microbiota-based therapy can reduce C diff recurrence in patients where donor microbiota and patient microbiota successfully converge.

Manipulating the expression of MAGEA3 can help block the growth of hepatocellular carcinoma.

Compared with participants with high physical activity and healthy sleep, those with no moderate-to-vigorous physical activity exhibited higher risks of all-cause, total cardiovascular, and total cancer mortality.

ZUMA-7 results indicate axicabtagene ciloleucel (Yescarta) improves event-free survival among adult patients with second-line relapsed or refractory large B-cell lymphoma (LBCL).

Topical and intravenous tranexamic acid (TXA) were found to significantly reduce blood loss compared with placebo in patients who have undergone bone surgery, suggesting that both administration methods may be effective at promoting wound healing.

Originally set to expire on June 30, 2021, the Oncology Care Model was extended for an additional year in light of the COVID-19 pandemic.

A heat wave affecting the Pacific Northwest region of the United States and parts of Canada is linked with hundreds of deaths; Arkansas sees a rise in COVID-19 cases; updates to federal funeral assistance program.

With systemic health and social inequalities contributing to a lack of health care access and a growing mortality risk among rural Americans, the COVID-19 pandemic has further exacerbated health issues present between community lines. We spotlight several health challenges in these communities and potential solutions to improve the general health of rural populations.

A new analysis may give clinicians a more in-depth understanding of an individual patient’s multiple sclerosis (MS) disease course.

A systematic review found significant evidence supporting self-management interventions for inflammatory arthritis, but also found it was difficult to draw conclusions about specific types of programs.

Robert A. Gabbay, MD, PhD, the chief science and medical officer at the American Diabetes Association (ADA), outlines why updates were made to the ADA’s Living Standards of Care.

Pediatric patients with atopic dermatitis (AD) often vary in disease severity and it can be difficult to assess how much of a topical therapy is needed, said Lawrence F. Eichenfield, MD, chief of pediatric and adolescent dermatology at Rady Children's Hospital-San Diego.

A recent study examined the prevalence and characteristics of 3 atypical pathogens responsible for respiratory tract infections in patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD), as well as evaluated optimal detection methods.

To mark National Gun Violence Awareness Month, The American Journal of Managed Care® assessed how events in 2020 shaped the United States' gun violence epidemic.

Vaccination rates among Medicaid beneficiaries remain low; Walmart introduces a less expensive insulin option; Moderna says its vaccine is effective against the delta variant.

New research illustrates the potential benefits of erenumab among migraineurs in the United States.

A new meta-analysis finds rigorous evidence lacking; however, existing data suggest preservative-free formulations of beta-blockers may work just as well as preserved beta-blockers in reducing intraocular pressure.

A new report suggests patients with persistent nail psoriasis may benefit from biologics like tildrakizumab.

Deepak L. Bhatt, MD, MPH, executive director of interventional cardiovascular programs at Brigham and Women’s Hospital Heart & Vascular Center and professor of medicine at Harvard Medical School, outlines the benefits of sotagliflozin for individuals with type 2 diabetes and chronic kidney disease or heart failure.